Overview
Mara Roth is an Endocrinologist in Seattle, Washington. Dr. Roth is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.
Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Follicular Thyroid Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4225 Roosevelt Way NE, Seattle, WA 98105
Additional Areas of Focus
Dr. Roth has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Gme Office University Of Washington
Richard Failor is an Endocrinologist in Seattle, Washington. Dr. Failor is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Pituitary Tumor, Thyroid Cancer, Anaplastic Thyroid Cancer, and Medullary Thyroid Carcinoma.
Franciscan Endocrine Associates At St. Joseph
Dali Chen, MD, PhD, FACE, is a board-certified endocrinologist specializing in diabetes, thyroiddiseases, pituitary diseases, adrenal diseases, osteoporosis, male hypogonadism and lipid disorders. Dr. Chen strives to provide the best endocrine care for his patients with thorough endocrine evaluation, in-depth counseling, appropriate treatment and adequate follow-up. Dr. Chen likes to discuss with his patients their options and welcomes their participation in their own care management. He is fluent in English and Chinese.Dr. Chen is a member of the American Medical Association (AMA), American Association of Clinical Endocrinologists (AACE) and fellow of the American College of Endocrinology (ACE). Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Diabetic Neuropathy, Type 2 Diabetes (T2D), Anaplastic Thyroid Cancer, and Follicular Thyroid Cancer.
Franciscan Endocrine Associates At St. Joseph
Zhiyu Wang, MD, PhD, specializes in general endocrinology and metabolic disorders. Board certified in internal medicine, Dr. Wang provides care for a wide range of conditions that include diabetes, lipid disorders, osteoporosis and glandular conditions such as thyroid, pituitary and adrenal diseases. In addition to his medical degree, he completed a fellowship in endocrinology and holds a PhD in anatomy and cell biology.Dr. Wang listens to patients and thoroughly discusses conditions and treatment options. He believes in making decisions as a team. For his patients who have long-term endocrine conditions, he strives to make sure they have the most current care to help live a happy and healthy life. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Follicular Thyroid Cancer. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Cancer, and Anaplastic Thyroid Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anaplastic Thyroid CancerDr. Roth isDistinguished. Learn about Anaplastic Thyroid Cancer.
- Follicular Thyroid CancerDr. Roth isDistinguished. Learn about Follicular Thyroid Cancer.
- Medullary Thyroid CarcinomaDr. Roth isDistinguished. Learn about Medullary Thyroid Carcinoma.
- Papillary Thyroid CancerDr. Roth isDistinguished. Learn about Papillary Thyroid Cancer.
- Thyroid CancerDr. Roth isDistinguished. Learn about Thyroid Cancer.
- Advanced
- Thyroid NoduleDr. Roth isAdvanced. Learn about Thyroid Nodule.
- Experienced
- Addison's DiseaseDr. Roth isExperienced. Learn about Addison's Disease.
- Adrenal CancerDr. Roth isExperienced. Learn about Adrenal Cancer.
- Adrenal Insufficiency PediatricDr. Roth isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Adrenocortical CarcinomaDr. Roth isExperienced. Learn about Adrenocortical Carcinoma.
- Familial Hypocalciuric Hypercalcemia Type 1
- Familial Isolated Hyperparathyroidism